OPTIMIZING CLINICAL AND SAFETY MONITORING IN PATIENTS TREATED WITH SECOND-GENERATION ANTIPSYCHOTICS
CE Hours
1.50
CE Units
0.150
Activity Type
- Application
Target Audience(s)
- Pharmacists
- PHARMACY TECHNICIANS
Accreditation(s)
The Colegio de Farmacéuticos de Puerto Rico is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
OPTIMIZING CLINICAL AND SAFETY MONITORING IN PATIENTS TREATED WITH SECOND-GENERATION ANTIPSYCHOTICS
OPTIMIZING CLINICAL AND SAFETY MONITORING IN PATIENTS TREATED WITH SECOND-GENERATION ANTIPSYCHOTICS
Objectives
- Identify the most common metabolic, cardiovascular, and neurological adverse effects associated with second-generation antipsychotics.
- Recognize the basic clinical and laboratory monitoring parameters recommended during treatment with these medications.
- Match specific medications (e.g., olanzapine, risperidone, clozapine) with their main clinical risks
- Select appropriate pharmaceutical interventions in response to common findings, such as weight gain, extrapyramidal symptoms, or hyperprolactinemia.
Activity Number
0151-0000-26-024-H01-P/T
Release Date:
Jul 20, 2026
Credit Expiration Date:
Jul 20, 2026
CE Hours
1.50